Literature DB >> 2860388

Abnormal vitamin D metabolism in Hodgkin's lymphoma.

M Davies, E B Mawer, M E Hayes, G A Lumb.   

Abstract

In the autumn of 1984 there was spontaneous correction of hypercalcaemia in a patient with Hodgkin's lymphoma. Hypercalcaemia recurred when ultraviolet radiation (UVR) was given and this abnormality was associated with high serum concentrations of 1,25-dihydroxyvitamin D3 (1,25[OH]2D3) although concentrations of precursor 25-hydroxyvitamin D3 were normal. Chemotherapy of Hodgkin's lymphoma corrected the hypercalcaemia and subsequent exposure to UVR did not produce either hypercalcaemia or a high serum 1,25(OH)2D3. Rigorous tests were applied to the putative 1,25(OH)2D3 produced during hypercalcaemia and it was not possible to separate this metabolite from 1,25(OH)2D3 itself. It is concluded that the hypercalcaemia was caused by abnormal vitamin D metabolism which was a result of the Hodgkin's lymphoma. Hodgkin's tissue may have been the site of excessive synthesis of 1,25(OH)2D3.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860388     DOI: 10.1016/s0140-6736(85)92864-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease.

Authors:  R Karmali; S Barker; M Hewison; L Fraher; D R Katz; J L O'Riordan
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 2.  1,25-Dihydroxyvitamin D-related hypercalcemia in lymphoma: two case reports.

Authors:  J P Devogelaer; M Lambert; B Boland; C Godfraind; H Noel; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

Review 3.  Calcium and vitamin D metabolism in granulomatous diseases.

Authors:  M Fuss; T Pepersack; C Gillet; R Karmali; J Corvilain
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

4.  Malignant hypercalcaemia.

Authors:  A K Bhalla
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

5.  Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritis.

Authors:  M E Hayes; D Bayley; P Still; J Palit; J Denton; A J Freemont; R G Cooper; E B Mawer
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 6.  Medical management of hypercalcaemia.

Authors:  S H Ralston
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

Review 7.  Current management of malignant hypercalcaemia.

Authors:  J C Stevenson
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

8.  Inhibition by prostaglandin E1 and E2 of 1,25-dihydroxyvitamin D3 synthesis by synovial fluid macrophages from arthritic joints.

Authors:  M E Hayes; A Rai; R G Cooper; D Bayley; A J Freemont; E B Mawer
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

9.  Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes.

Authors:  D A Fetchick; D R Bertolini; P S Sarin; S T Weintraub; G R Mundy; J F Dunn
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

10.  Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy.

Authors:  Katie N Evans; Harris Taylor; Daniel Zehnder; Mark D Kilby; Judith N Bulmer; Farah Shah; John S Adams; Martin Hewison
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.